Proton Versus Intensity-Modulated Radiotherapy for Prostate Cancer: Patterns of Care and Early Toxicity

2012171 citationsJournal Articlebronze Open Access

Authors

James B. Yu · Health Research and Educational Trust

Pamela R. Soulos · Smilow Cancer Hospital

Jeph Herrin · Health Research and Educational Trust

Laura D. Cramer · Yale Cancer Center

Arnold L. Potosky · Health Research and Educational Trust

Kenneth B. Roberts · Yale Cancer Center

Cary P. Gross

Abstract

Although PRT is substantially more costly than IMRT, there was no difference in toxicity in a comprehensive cohort of Medicare beneficiaries with prostate cancer at 12 months post-treatment.

Topics & Keywords

Advanced Radiotherapy Techniques Radiation Therapy and Dosimetry Prostate Cancer Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JNCI Journal of the National Cancer Institute

Volume 105, Issue 1, pp. 25-32

DOI: 10.1093/jnci/djs463

Field-Weighted Citation Impact: 22.04